| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |